 Connection
Noah Johnson to Alzheimer Disease
This is a "connection" page, showing publications Noah Johnson has written about Alzheimer Disease.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.763 |
|
|
|
-
Johnson NR, Wang AC, Coughlan C, Sillau S, Lucero E, Viltz L, Markham N, Allen C, Dhanasekaran AR, Chial HJ, Potter H. Imipramine and olanzapine block apoE4-catalyzed polymerization of A? and show evidence of improving Alzheimer's disease cognition. Alzheimers Res Ther. 2022 06 29; 14(1):88.
Score: 0.521
-
Coughlan C, Lindenberger J, Jacot JG, Johnson NR, Anton P, Bevers S, Welty R, Graner MW, Potter H. Specific Binding of Alzheimer's A? Peptides to Extracellular Vesicles. Int J Mol Sci. 2024 Mar 26; 25(7).
Score: 0.147
-
Johnson NR, Condello C, Guan S, Oehler A, Becker J, Gavidia M, Carlson GA, Giles K, Prusiner SB. Evidence for sortilin modulating regional accumulation of human tau prions in transgenic mice. Proc Natl Acad Sci U S A. 2017 12 19; 114(51):E11029-E11036.
Score: 0.095
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|